After a long wait, on October 21st, the Hanoi Medical University Vaccination Clinic officially began administering the dengue fever vaccine to individuals aged 4 years and older. This marks the first time a dengue vaccine has been available in Vietnam, representing a significant advancement in the prevention and control of dengue fever.
Qdenga was first approved for use in Indonesia in 2022, followed by approvals in the United Kingdom, Brazil, Argentina, Indonesia, Thailand, and Malaysia. Qdenga was approved in Europe in 2023. To date, the Qdenga vaccine has been widely deployed in nearly 40 countries. The vaccine was licensed for circulation in Vietnam by the Ministry of Health on May 15, 2024. This is the first dengue vaccine to be circulated in Vietnam. Below is information about the Qdenga vaccine.
1. Vaccine Name:
Qdenga. The Qdenga vaccine prevents dengue virus strains and is indicated for individuals aged 4 years and older, demonstrating an efficacy of up to 80% and reducing the risk of hospitalization by over 90% when infected. Notably, for individuals who have previously contracted dengue fever, vaccination provides high efficacy against re-infection.
2. Disease Prevention:
According to the manufacturer, the Qdenga vaccine can protect against all four dengue virus serotypes (DEN-1, DEN-2, DEN-3, and DEN-4) and is indicated for the prevention of dengue fever in individuals aged 4 years and older, especially in areas where dengue fever is endemic.
3. Country of Manufacture:
The Qdenga vaccine was developed by Takeda Pharmaceutical Company and manufactured in Germany.
4. Target Population:
- Indications: The Qdenga vaccine is used for children aged 4 years and older, and adults.
- Contraindications:
Individuals hypersensitive to any component of the vaccine or to a previous dose.
Immunocompromised individuals undergoing immunosuppressive therapy such as chemotherapy or high-dose corticosteroids (prednisone 20mg/day) within 4 weeks prior to vaccination, as well as other live attenuated vaccines.
Individuals with symptomatic HIV infection or asymptomatic HIV infection with evidence of immunodeficiency.
Pregnant women, breastfeeding women.
5. Dosage, Administration Route:
The Qdenga vaccine is administered as a 0.5ml dose via subcutaneous injection, preferably in the upper arm (deltoid region).
6. Vaccination Schedule:
The Qdenga vaccine is administered according to a 2-dose schedule, with a 3-month interval between doses.
7. Vaccine Price:
The reference price for the Qdenga vaccine at the Hanoi Medical University Vaccination Clinic is 1,360,000 VND per dose.
---------------------------------------------------------
For all information and direct consultation, please contact:
HANOI MEDICAL UNIVERSITY VACCINATION CLINIC, CAMPUS 1
- No. 1 Ton That Tung, Dong Da, Hanoi.
- Working hours: Monday to Sunday morning weekly
- Morning: 8:00 AM - 11:30 AM / Afternoon: 1:30 PM - 4:30 PM
- Phone: 02462597231
- Email: tiemchungytcc@gmail.com
- Facebook: https://www.facebook.com/phongtiemchungdhy/
- Like our Page to get the fastest updates on vaccine availability!